SQSTM1 and Nephropathy: However, Br-MSCs + EXO, EXOs, and Br-MSCs’ administration showed significant downregulation in the mean value of renal P62 mRNA and protein expression compared with the nephropathy and CM-treated groups, respectively (Figure 9A,E–H).